BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23023426)

  • 1. [The role of microRNA-210 in esophageal squamous cell carcinoma].
    Tsuchiya S
    Yakugaku Zasshi; 2012; 132(9):1069-73. PubMed ID: 23023426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).
    Tsuchiya S; Fujiwara T; Sato F; Shimada Y; Tanaka E; Sakai Y; Shimizu K; Tsujimoto G
    J Biol Chem; 2011 Jan; 286(1):420-8. PubMed ID: 21044961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-127 is a tumor suppressor in human esophageal squamous cell carcinoma through the regulation of oncogene FMNL3.
    Gao X; Wang X; Cai K; Wang W; Ju Q; Yang X; Wang H; Wu H
    Eur J Pharmacol; 2016 Nov; 791():603-610. PubMed ID: 27645894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET.
    Chen Z; Lin J; Wu S; Xu C; Chen F; Huang Z
    Exp Cell Res; 2018 Jan; 362(1):90-101. PubMed ID: 29126868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.
    Li B; Xu WW; Han L; Chan KT; Tsao SW; Lee NPY; Law S; Xu LY; Li EM; Chan KW; Qin YR; Guan XY; He QY; Cheung ALM
    Oncogene; 2017 Jul; 36(28):3986-4000. PubMed ID: 28288140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
    Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
    Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-202 inhibits tumor progression by targeting LAMA1 in esophageal squamous cell carcinoma.
    Meng X; Chen X; Lu P; Ma W; Yue D; Song L; Fan Q
    Biochem Biophys Res Commun; 2016 May; 473(4):821-827. PubMed ID: 27045085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.
    Osako Y; Seki N; Kita Y; Yonemori K; Koshizuka K; Kurozumi A; Omoto I; Sasaki K; Uchikado Y; Kurahara H; Maemura K; Natsugoe S
    Int J Oncol; 2016 Dec; 49(6):2255-2264. PubMed ID: 27779648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
    Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
    Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-203 inhibits the progression of esophageal squamous cell carcinoma with restored epithelial tissue architecture in vivo.
    Okumura T; Shimada Y; Moriyama M; Takei Y; Omura T; Sekine S; Nagata T; Shimizu K; Tsukada K
    Int J Oncol; 2014 Jun; 44(6):1923-32. PubMed ID: 24692008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma.
    Pan F; Mao H; Bu F; Tong X; Li J; Zhang S; Liu X; Wang L; Wu L; Chen R; Wei H; Li B; Li C; Yang Y; Steer CJ; Zhao J; Guo Y
    Oncotarget; 2017 Jan; 8(4):5735-5752. PubMed ID: 27974696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS.
    Zhu L; Wang Z; Fan Q; Wang R; Sun Y
    Oncol Rep; 2014 Jan; 31(1):280-6. PubMed ID: 24154848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-1 in esophageal squamous cell carcinoma correlates with an advanced clinical stage and its overexpression inhibits cell migration and invasion.
    Yao L; Zhang Y; Zhu Q; Li X; Zhu S; Gong L; Han X; Lan M; Li S; Zhang W; Li Y
    Int J Mol Med; 2015 Apr; 35(4):1033-41. PubMed ID: 25672418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.
    Jin L; Yi J; Gao Y; Han S; He Z; Chen L; Song H
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):810-9. PubMed ID: 27563011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
    Mao Y; Liu J; Zhang D; Li B
    Tumour Biol; 2016 Jul; 37(7):9009-22. PubMed ID: 26758433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-100 suppresses the proliferation and tumor growth of esophageal squamous cancer cells via targeting CXCR7.
    Zhou SM; Zhang F; Chen XB; Jun CM; Jing X; Wei DX; Xia Y; Zhou YB; Xiao XQ; Jia RQ; Li JT; Sheng W; Zeng Y
    Oncol Rep; 2016 Jun; 35(6):3453-9. PubMed ID: 27035873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
    Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
    Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.
    Song C; Lu P; Shi W; Sun G; Wang G; Huang X; Wang Z; Wang Z
    Biomed Pharmacother; 2016 Oct; 83():843-849. PubMed ID: 27501502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.